United Therapeutics Corporation
(UTHR - NASDAQ)
572,57 USD
📋 Profilo Aziendale

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

|